NVIDIA BioNeMo
Accelerate early drug discovery with generative AI.
What Is BioNeMo?
NVIDIA BioNeMo™ is a generative AI platform for drug discovery that simplifies and accelerates training models on your own data and helps ensure easy and scalable deployment of models for drug discovery applications. Offering the quickest path to speed and scale for both AI model development and deployment, BioNeMo accelerates the journey to AI-powered drug discovery.
Accelerate AI-Powered Drug Discovery With BioNeMo
Learn how BioNeMo’s user-friendly interface and optimized training and inferencing routines are paired with on-demand supercomputing infrastructure to support the most expensive, time-consuming stages of early drug discovery pipelines. BioNeMo is a part of NVIDIA AI Foundations—a set of model-making services that advance enterprise-level generative AI. It enables model customization across use cases in areas such as text (NVIDIA NeMo™), visual content (NVIDIA Picasso), and biology (NVIDIA BioNeMo).
Explore Features and Benefits
State-of-the-Art Biomolecular Models for AI Drug Discovery
Customize and deploy AI models for 3D protein structure prediction, de novo protein and small molecule generation, property predictions, and molecular docking.
Turnkey Solution Through a Web Interface or Cloud APIs
Access pretrained models through cloud APIs or an easy-to-use web interface for interactive inference, visualization, and experimentation.
Training and Optimization on an AI Supercomputer in the Cloud
Optimize and train models with NVIDIA DGX™ Cloud, the multi-node AI training-as-a-service solution.
Sign up for early access to BioNeMo.